Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
O-I Glass | OI | 28. mar 2025 | 11.54 | -3.99 |
Oak Valley Bancorp | OVLY | 28. mar 2025 | 25.12 | -0.51 |
Oak Woods Acquisition | OAKU | 28. mar 2025 | 11.56 | 0.00 |
Oaktree Acquisition III Life Sciences | OACC | 28. mar 2025 | 10.22 | 0.00 |
Oaktree Acquisition III Life Sciences Unit | OACCU | 28. mar 2025 | 10.33 | +0.19 |
Oaktree Capital A Pref | OAK-A | 28. mar 2025 | 21.78 | +0.05 |
Oaktree Capital Group B Pref | OAK-B | 28. mar 2025 | 21.53 | +1.22 |
Oaktree Specialty | OCSL | 28. mar 2025 | 15.50 | -0.70 |
Oatly ADR | OTLY | 28. mar 2025 | 9.90 | +0.30 |
Oblong | OBLG | 28. mar 2025 | 3.49 | +0.81 |
Occidental Petroleum | OXY | 28. mar 2025 | 48.83 | -1.37 |
Ocean Biomedical | OCEA | 28. mar 2025 | 0.06 | -18.46 |
Ocean Power Technologies | OPTT | 28. mar 2025 | 0.47 | -1.86 |
Oceaneering International | OII | 28. mar 2025 | 21.60 | -1.68 |
OceanFirst Financial | OCFC | 28. mar 2025 | 17.06 | -1.10 |
OceanFirst Pref | OCFCP | 28. mar 2025 | 25.30 | 0.00 |
OceanPal | OP | 28. mar 2025 | 0.87 | +0.01 |
Ocugen | OCGN | 28. mar 2025 | 0.80 | +10.44 |
Ocular Therapeutix | OCUL | 28. mar 2025 | 7.58 | -2.19 |
Oculis | OCS | 28. mar 2025 | 19.18 | -1.13 |
Oddity Tech | ODD | 28. mar 2025 | 42.94 | -1.54 |
Odysight.ai | ODYS | 28. mar 2025 | 6.80 | 0.00 |
Odyssey Marine Exploration | OMEX | 28. mar 2025 | 0.41 | -4.66 |
Offerpad Solutions A | OPAD | 28. mar 2025 | 1.70 | -5.56 |
Office Properties | OPI | 28. mar 2025 | 0.48 | -4.35 |
OFG Bancorp | OFG | 28. mar 2025 | 40.24 | -1.78 |
OFS Capital | OFS | 28. mar 2025 | 8.99 | -0.11 |
OFS Credit | OCCI | 28. mar 2025 | 6.19 | -0.16 |
OFS Credit C Pref | OCCIO | 28. mar 2025 | 24.70 | 0.00 |
OFS Credit Company Pref F | OCCIM | 28. mar 2025 | 24.65 | -0.41 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.